Funding round brings in $15M for Pa. biotech

05/6/2013 | American City Business Journals

AltheRx Pharmaceuticals secured $15 million in its latest funding round. The Exton, Pa.-based firm plans to use the money to bring Solabegron, its lead drug candidate for overactive bladder, into late-stage trials. AltheRx also appointed Jim Bennethum, former executive vice president of Becker Ventures, as its new CEO.

View Full Article in:

American City Business Journals

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Stop Loss Sales Executive
Blue Cross Blue Shield of Massachusetts
Boston, MA
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Senior Director, Research
America's Heatlh Insurance Plans (AHIP)
Washington, DC